Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

May 2013 - FRMC

05/17/2013
Personalized medicine is promising to revolutionize medical care by tailoring diagnostic and therapeutic approaches to individual patients based on an improved understanding of genetics and molecular biology.
Personalized medicine is promising to revolutionize medical care by tailoring diagnostic and therapeutic approaches to individual patients based on an improved understanding of genetics and molecular biology.
Personalized medicine is...
05/17/2013
First Report Managed Care
05/17/2013
More than a quarter of patients with HIV treated with antiretroviral therapy (ART) do not adhere to therapy, according to a study presented during a poster session at the AMCP meeting.
More than a quarter of patients with HIV treated with antiretroviral therapy (ART) do not adhere to therapy, according to a study presented during a poster session at the AMCP meeting.
More than a quarter of patients...
05/17/2013
First Report Managed Care
05/17/2013
The Centers for Medicare & Medicaid Services (CMS) Star Ratings program has heightened plan sponsors’ attention for the need to improve medication adherence and other aspects of medication use.
The Centers for Medicare & Medicaid Services (CMS) Star Ratings program has heightened plan sponsors’ attention for the need to improve medication adherence and other aspects of medication use.
The Centers for Medicare &...
05/17/2013
First Report Managed Care
05/17/2013
Switching oral contraceptive (OC) users to a low-dose levonorgestrel-intrauterine (LNG-IUS) system may result in overall cost savings for healthcare plans, due to subsequent decreases in pharmacy costs and a decrease in medical costs related...
Switching oral contraceptive (OC) users to a low-dose levonorgestrel-intrauterine (LNG-IUS) system may result in overall cost savings for healthcare plans, due to subsequent decreases in pharmacy costs and a decrease in medical costs related...
Switching oral contraceptive...
05/17/2013
First Report Managed Care
05/17/2013
Between 2007 and 2011, specialty drug costs grew from 15% to 20% each year, whereas spending on traditional drugs increased <5% each year, according to the Express Scripts 2011 drug trend report.
Between 2007 and 2011, specialty drug costs grew from 15% to 20% each year, whereas spending on traditional drugs increased <5% each year, according to the Express Scripts 2011 drug trend report.
Between 2007 and 2011, specialty...
05/17/2013
First Report Managed Care
05/17/2013
Patients with nonmetastatic HER2+ breast cancer who were administered trastuzumab in an outpatient hospital setting incurred higher total monthly healthcare costs compared with patients treated in an office clinic, according to information...
Patients with nonmetastatic HER2+ breast cancer who were administered trastuzumab in an outpatient hospital setting incurred higher total monthly healthcare costs compared with patients treated in an office clinic, according to information...
Patients with nonmetastatic...
05/17/2013
First Report Managed Care
05/17/2013
San Diego—For managed care professionals, rheumatoid arthritis (RA) is among the most expensive and difficult diseases to manage. The FDA has approved several drugs to treat the disease, but it is sometimes hard to determine the option that...
San Diego—For managed care professionals, rheumatoid arthritis (RA) is among the most expensive and difficult diseases to manage. The FDA has approved several drugs to treat the disease, but it is sometimes hard to determine the option that...
San Diego—For managed care...
05/17/2013
First Report Managed Care
05/17/2013
The Medicaid system includes patients described as complex, who comprise a challenging and transient group of patients. 
The Medicaid system includes patients described as complex, who comprise a challenging and transient group of patients. 
The Medicaid system includes...
05/17/2013
First Report Managed Care

News

News
05/17/2013
In the United States, approximately 400,000 people have multiple sclerosis (MS). Each day, there are approximately 200 new diagnoses of the disease, presenting a burden on patients who typically live with MS for 20 to 40 years as well as the...
In the United States, approximately 400,000 people have multiple sclerosis (MS). Each day, there are approximately 200 new diagnoses of the disease, presenting a burden on patients who typically live with MS for 20 to 40 years as well as the...
In the United States,...
05/17/2013
First Report Managed Care
News
05/17/2013
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs...
05/17/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement